MicroRNA-196a2 Biomarker and Targetome Network Analysis in Solid Tumors

Affiliations

12 January 2016

-

doi: 10.1007/s40291-016-0223-2


Abstract

Introduction: MicroRNAs (miRNAs) have been linked to cancer development and progression. The molecular mechanisms underlying the genetic associations of the miRNA single nucleotide polymorphism with cancer vary by cancer site. As there are no previous studies on the miR-196a2 variant or expression in any type of cancer among our population, we aimed to determine the expression profile of mature miR-196a2 in various types of solid tumors and to analyze the impact of its polymorphism (rs11614913; C/T) on the expression levels.

Materials and methods: The study included 230 cancer patients (including 17 types of cancer), 26 patients with pre-cancer lesions, and 100 unrelated controls. Archived formalin-fixed, paraffin-embedded specimens (n = 197) were available for both miRNA expression analysis and single nucleotide polymorphism identification. Venous blood was collected from 59 histologically confirmed sporadic cancer patients and the study controls for single nucleotide polymorphism identification. Real-time polymerase chain reaction analysis was performed for allelic discrimination and relative quantification of miR-196a2 in the study samples. In silico target gene prediction and network analysis was performed.

Results: We found that individuals with the T variant were associated with cancer risk under all genetic association models, especially in colorectal, esophageal, skin, lung, thyroid, and renal cancer. Overall and stratified analysis showed miR-196a2 over-expression in most of the current malignant tumor samples relative to their corresponding cancer-free tissues. Carriers of the C allele had significantly higher expression levels of miR-196a2. Correlation with the clinicopathological features of cancer showed organ-specific effects. Gene enrichment analysis of predicted and validated targets speculated the putative role of miR-196a2 in cancer-associated biology.

Conclusions: We highlighted cancer-type specific expression profiles of miR-196a2, which was correlated with the clinicopathological features in various types of cancer. Taken together, our results suggest that the miRNA signature could have promising diagnostic and prognostic significance.


Similar articles

MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population.

Wei J, Zheng L, Liu S, Yin J, Wang L, Wang X, Shi Y, Shao A, Tang W, Ding G, Liu C, Chen S, Gu H.Hum Immunol. 2013 Sep;74(9):1199-205. doi: 10.1016/j.humimm.2013.06.012. Epub 2013 Jun 17.PMID: 23792053

Somatic Mutation of the SNP rs11614913 and Its Association with Increased MIR 196A2 Expression in Breast Cancer.

Zhao H, Xu J, Zhao D, Geng M, Ge H, Fu L, Zhu Z.DNA Cell Biol. 2016 Feb;35(2):81-7. doi: 10.1089/dna.2014.2785. Epub 2015 Dec 28.PMID: 26710106

Micro-RNA 196a2 expression and miR-196a2 (rs11614913) polymorphism in T1DM: a pilot study.

Ibrahim AA, Ramadan A, Wahby AA, Hassan M, Soliman HM, Abdel Hamid TA.J Pediatr Endocrinol Metab. 2019 Oct 25;32(10):1171-1179. doi: 10.1515/jpem-2019-0226.PMID: 31472066

Comprehensive assessment of the association between miRNA polymorphisms and gastric cancer risk.

Xu Q, Liu JW, Yuan Y.Mutat Res Rev Mutat Res. 2015 Jan-Mar;763:148-60. doi: 10.1016/j.mrrev.2014.09.004. Epub 2014 Oct 12.PMID: 25795117 Review.

rs11614913 polymorphism in miRNA-196a2 and cancer risk: an updated meta-analysis.

Liu Y, He A, Liu B, Zhong Y, Liao X, Yang J, Chen J, Wu J, Mei H.Onco Targets Ther. 2018 Mar 1;11:1121-1139. doi: 10.2147/OTT.S154211. eCollection 2018.PMID: 29535537 Free PMC article. Review.


Cited by

Analysis of MIR27A (rs11671784) Variant Association with Systemic Lupus Erythematous.

Khired ZA, Kattan SW, Alzahrani AK, Milebary AJ, Hussein MH, Qusti SY, Alshammari EM, Toraih EA, Fawzy MS.Life (Basel). 2023 Mar 5;13(3):701. doi: 10.3390/life13030701.PMID: 36983856 Free PMC article.

Diagnostic and Prognostic Risk Assessment of Heat Shock Protein HSPA1B rs2763979 Gene Variant in Asthma.

Faisal S, Abdelaal S, Jeraiby MA, Toaimah FHS, Kattan SW, Abdel-Gawad AR, Riad E, Toraih EA, Fawzy MS, Ibrahim A.Genes (Basel). 2022 Dec 16;13(12):2391. doi: 10.3390/genes13122391.PMID: 36553658 Free PMC article.

Migration/Differentiation-Associated LncRNA SENCR rs12420823*C/T: A Novel Gene Variant Can Predict Survival and Recurrence in Patients with Breast Cancer.

Al Ageeli E, Attallah SM, Mohamed MH, Almars AI, Kattan SW, Toraih EA, Fawzy MS, Darwish MK.Genes (Basel). 2022 Oct 31;13(11):1996. doi: 10.3390/genes13111996.PMID: 36360233 Free PMC article.

A Review and In Silico Analysis of Tissue and Exosomal Circular RNAs: Opportunities and Challenges in Thyroid Cancer.

Toraih EA, Hussein MH, Fawzy MS, Kandil E.Cancers (Basel). 2022 Sep 28;14(19):4728. doi: 10.3390/cancers14194728.PMID: 36230649 Free PMC article. Review.

A miRNA-Based Prognostic Model to Trace Thyroid Cancer Recurrence.

Toraih EA, Fawzy MS, Ning B, Zerfaoui M, Errami Y, Ruiz EM, Hussein MH, Haidari M, Bratton M, Tortelote GG, Hilliard S, Nilubol N, Russell JO, Shama MA, El-Dahr SS, Moroz K, Hu T, Kandil E.Cancers (Basel). 2022 Aug 26;14(17):4128. doi: 10.3390/cancers14174128.PMID: 36077665 Free PMC article.


KMEL References


References

  1.  
    1. Bioinformatics. 2015 May 1;31(9):1502-4 - PubMed
  2.  
    1. Hum Mutat. 2009 Jan;30(1):79-84 - PubMed
  3.  
    1. J Hum Genet. 2010 Aug;55(8):495-9 - PubMed
  4.  
    1. Anticancer Res. 2013 Jun;33(6):2561-7 - PubMed
  5.  
    1. DNA Cell Biol. 2016 Feb;35(2):81-7 - PubMed
  6.  
    1. PLoS One. 2011;6(5):e20471 - PubMed
  7.  
    1. Pathology. 2010 Dec;42(7):669-73 - PubMed
  8.  
    1. Br J Cancer. 2014 Mar 4;110(5):1260-8 - PubMed
  9.  
    1. Mol Cell. 2010 May 14;38(3):323-32 - PubMed
  10.  
    1. PLoS One. 2012;7(1):e30585 - PubMed
  11.  
    1. Cancer Lett. 2014 Mar 28;344(2):147-56 - PubMed
  12.  
    1. PLoS One. 2013;8(3):e58564 - PubMed
  13.  
    1. Am J Pathol. 2009 May;174(5):1940-8 - PubMed
  14.  
    1. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1183-7 - PubMed
  15.  
    1. PLoS One. 2011 Mar 31;6(3):e18108 - PubMed
  16.  
    1. Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):E4884-93 - PubMed
  17.  
    1. JAMA. 2007 May 2;297(17):1901-8 - PubMed
  18.  
    1. Cold Spring Harb Protoc. 2012 Mar 01;2012(3):297-306 - PubMed
  19.  
    1. Clin Chem Lab Med. 2011 Sep 09;49(12):2073-80 - PubMed
  20.  
    1. Ann Oncol. 2013 Oct;24(10):2581-8 - PubMed
  21.  
    1. J Thorac Cardiovasc Surg. 2012 Oct;144(4):794-807 - PubMed
  22.  
    1. Hum Immunol. 2010 Jun;71(6):621-6 - PubMed
  23.  
    1. Clin Cancer Res. 2010 Aug 15;16(16):4289-97 - PubMed
  24.  
    1. Dig Dis Sci. 2011 Feb;56(2):602-9 - PubMed
  25.  
    1. Hum Mutat. 2010 Jan;31(1):E1052-7 - PubMed
  26.  
    1. Genet Med. 2002 Mar-Apr;4(2):45-61 - PubMed
  27.  
    1. Int J Mol Sci. 2015 Aug 21;16(8):19886-919 - PubMed
  28.  
    1. Bioinformatics. 2015 Jul 15;31(14):2403-5 - PubMed
  29.  
    1. Nature. 2005 Dec 1;438(7068):671-4 - PubMed
  30.  
    1. PLoS One. 2014 Feb 26;9(2):e89930 - PubMed
  31.  
    1. Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61 - PubMed
  32.  
    1. Oncol Rep. 2015 Aug;34(2):877-83 - PubMed
  33.  
    1. Biomed Rep. 2013 Sep;1(5):737-742 - PubMed
  34.  
    1. Genes Chromosomes Cancer. 2012 Apr;51(4):394-401 - PubMed
  35.  
    1. Cancer Cell Int. 2014 Dec 14;14(1):128 - PubMed
  36.  
    1. Nature. 2005 Jun 9;435(7043):834-8 - PubMed
  37.  
    1. J Cancer Res Clin Oncol. 2010 Dec;136(12):1853-9 - PubMed
  38.  
    1. Cancer Med. 2014 Aug;3(4):878-88 - PubMed
  39.  
    1. Br J Cancer. 2011 Mar 15;104(6):893-8 - PubMed
  40.  
    1. Oncogene. 2008 Nov 6;27(52):6667-78 - PubMed
  41.  
    1. Nucleic Acids Res. 2014 Jan;42(Database issue):D78-85 - PubMed
  42.  
    1. Biomed Res Int. 2014;2014:468605 - PubMed
  43.  
    1. Cancer Genet. 2013 Jun;206(6):217-21 - PubMed
  44.  
    1. Dev Cell. 2008 Nov;15(5):749-61 - PubMed
  45.  
    1. Brief Bioinform. 2016 Mar;17 (2):193-203 - PubMed
  46.  
    1. Mol Diagn Ther. 2015 Jun;19(3):179-90 - PubMed
  47.  
    1. Int J Mol Sci. 2014 Apr 17;15(4):6544-55 - PubMed
  48.  
    1. PLoS One. 2013 Apr 12;8(4):e61047 - PubMed
  49.  
    1. Nat Rev Cancer. 2010 Jun;10(6):389-402 - PubMed
  50.  
    1. Nucleic Acids Res. 2008 Jan;36(Database issue):D165-9 - PubMed
  51.  
    1. OMICS. 2015 Jan;19(1):24-30 - PubMed
  52.  
    1. World J Gastroenterol. 2009 May 7;15(17):2089-96 - PubMed
  53.  
    1. PLoS One. 2014 Feb 04;9(2):e87897 - PubMed
  54.  
    1. Cancer Res. 2012 Mar 1;72(5):1126-36 - PubMed
  55.  
    1. Nucleic Acids Res. 2015 Jan;43(Database issue):D153-9 - PubMed
  56.  
    1. Oncogene. 2013 Jun 20;32(25):3071-9 - PubMed
  57.  
    1. Nucleic Acids Res. 2004 Jan 1;32(Database issue):D277-80 - PubMed
  58.  
    1. Dig Dis Sci. 2010 Aug;55(8):2288-93 - PubMed
  59.  
    1. J Viral Hepat. 2011 Jul;18(7):e399-407 - PubMed
  60.  
    1. Ann Surg Oncol. 2013 Dec;20 Suppl 3:S406-14 - PubMed
  61.  
    1. Clin Cancer Res. 2010 Jul 15;16(14):3713-20 - PubMed
  62.  
    1. J Cell Mol Med. 2011 Jan;15(1):14-23 - PubMed
  63.  
    1. Lab Invest. 2009 May;89(5):597-606 - PubMed
  64.  
    1. Clin Chem. 2009 Apr;55(4):611-22 - PubMed
  65.  
    1. Meta Gene. 2014 Mar 28;2:226-36 - PubMed
  66.  
    1. Bioinformatics. 2013 Mar 1;29(5):638-44 - PubMed
  67.  
    1. Helicobacter. 2010 Dec;15(6):524-31 - PubMed
  68.  
    1. BMC Cancer. 2012 Aug 09;12:348 - PubMed
  69.  
    1. Mol Med Rep. 2009 Nov-Dec;2(6):963-70 - PubMed
  70.  
    1. Nucleic Acids Res. 2009 Jan;37(Database issue):D98-104 - PubMed
  71.  
    1. Nucleic Acids Symp Ser (Oxf). 2004;(48):211-2 - PubMed
  72.  
    1. Nucleic Acids Res. 2012 Jul;40(Web Server issue):W498-504 - PubMed
  73.  
    1. Int J Clin Exp Pathol. 2015 Mar 01;8(3):2461-72 - PubMed
  74.  
    1. Int J Clin Exp Pathol. 2015 Apr 01;8(4):4132-7 - PubMed
  75.  
    1. Nucleic Acids Res. 2005 Sep 28;33(17):5394-403 - PubMed
  76.  
    1. RNA. 2003 Feb;9(2):175-9 - PubMed
  77.  
    1. J Clin Invest. 2008 Jul;118(7):2600-8 - PubMed
  78.  
    1. Asian Pac J Cancer Prev. 2015;16(5):1781-7 - PubMed
  79.  
    1. Oncogene. 2009 Mar 19;28(11):1432-42 - PubMed
  80.  
    1. Lung Cancer. 2010 Jul;69(1):127-9 - PubMed
  81.  
    1. Cell Mol Life Sci. 2010 Oct;67(20):3535-48 - PubMed
  82.  
    1. Cancer Res. 2010 Oct 15;70(20):7894-904 - PubMed
  83.  
    1. Neuro Oncol. 2014 May;16(5):652-61 - PubMed
  84.  
    1. J Prev Med Public Health. 2011 May;44(3):125-30 - PubMed
  85.  
    1. Genome Biol. 2010 Jan 20;11(1):R6 - PubMed
  86.  
    1. Cancer Lett. 2010 Nov 28;297(2):137-43 - PubMed
  87.  
    1. PLoS One. 2013 Sep 10;8(9):e73009 - PubMed
  88.  
    1. Oncol Rep. 2007 Apr;17(4):753-60 - PubMed
  89.  
    1. Dev Biol. 2007 Feb 1;302(1):1-12 - PubMed
  90.  
    1. J Exp Zool B Mol Dev Evol. 2005 Jan 15;304(1):75-85 - PubMed
  91.  
    1. Hepatology. 2010 May;51(5):1494-504 - PubMed
  92.  
    1. Cell Commun Signal. 2009 Aug 10;7:18 - PubMed
  93.  
    1. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011 Feb;27(2):166-9 - PubMed
  94.  
    1. Oncotarget. 2015 Jul 30;6(21):18631-40 - PubMed
  95.  
    1. Leukemia. 2013 Jan;27(1):16-23 - PubMed
  96.  
    1. DNA Cell Biol. 2012 Mar;31(3):350-4 - PubMed
  97.  
    1. Biochim Biophys Acta. 2014 Oct;1842(10):1910-1922 - PubMed
  98.  
    1. Chin J Cancer Res. 2014 Jun;26(3):315-22 - PubMed
  99.  
    1. Int J Cancer. 2011 Sep 1;129(5):1064-74 - PubMed
  100.  
    1. Am J Respir Cell Mol Biol. 2009 Nov;41(5):544-52 - PubMed
  101.  
    1. J Clin Endocrinol Metab. 2011 Nov;96(11):3326-36 - PubMed
  102.  
    1. PLoS One. 2013 Nov 29;8(11):e81967 - PubMed
  103.  
    1. Biochim Biophys Acta. 2014 Apr;1845(2):255-65 - PubMed
  104.  
    1. Intern Med J. 2012 Jun;42(6):e115-9 - PubMed
  105.  
    1. PLoS One. 2013;8(3):e57841 - PubMed
  106.  
    1. Nucleic Acids Res. 2006 Jan 1;34(Database issue):D135-9 - PubMed
  107.  
    1. Biomed Pharmacother. 2015 May;72:1-5 - PubMed
  108.  
    1. Cancer Prev Res (Phila). 2008 Nov;1(6):460-9 - PubMed
  109.  
    1. Oncogene. 2007 Jun 28;26(30):4442-52 - PubMed
  110.  
    1. Cancer Res. 2009 Jul 15;69(14):5970-7 - PubMed
  111.  
    1. Mol Cancer Ther. 2012 Apr;11(4):842-52 - PubMed
  112.  
    1. Mol Biol Rep. 2012 Jan;39(1):269-75 - PubMed
  113.  
    1. Mol Biol Rep. 2011 Mar;38(3):1609-15 - PubMed
  114.  
    1. Nat Methods. 2013 Nov;10(11):1063-7 - PubMed